That is below the 30% rate reported at an interim stage of the study at the International Liver Congress earlier this year, but still sufficient for GSK to take the drug forward into a phase 3 ...

Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...

GSK shares last traded at GBX 1,511 ($19.59), with a volume of 9,054,711 shares. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold ...

In work conducted by Jining Medical University investigators, synthesis and optimization of a previously reported ...

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

Pfizer Inc. is poised to raise about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, ...

Haleon was a joint venture between Pfizer and GSK before being listed in London as a separate company in 2022. GSK sold its remaining 4.2% holding in Haleon in May last year. Comments and questions to ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax ... years has been dominated by Pfizer's Prevnar franchise. GSK said it is paying $2.1 billion upfront for Cambridge ...

Pfizer has exited Haleon through four block trades, the most recent of which was its sale of a 7.7% stake in January at a 2.75% discount. GSK sold its last shares in the company last year. Also on ...

Qualcomm has announced a trio of chipsets for gaming handhelds: the G3 Gen 3, G2 Gen 2, and G1 Gen 2. The G3 is the flagship, but sadly lacks the Oryon CPU or Adreno 830 GPU found in the smartphone ...